Brief: Arcutis Announces Chief Financial Officer Transition
10/04/2025 21:36
Arcutis Biotherapeutics Inc ARQT.O: ARCUTIS ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION ARCUTIS BIOTHERAPEUTICS INC - CFO DAVID TOPPER TO RETIRE ARCUTIS BIOTHERAPEUTICS INC - LATHA VAIRAVAN TO ASSUME ROLE OF CFO AT ARCUTIS Source text: ID:nGNX9ljMCw Further company coverage: ARQT.O
Recent news on Arcutis Biotherapeutics
See all newsBrief: Arcutis Canada Przoryve Cream 0.05% Receives Health Canada Approval For Atopic Dermatitis
Arcutis Biotherapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Arcutis Q2 revenue rises on demand for ZORYVE, lifts 2026 sales outlook
Arcutis Biotherapeutics Inc expected to post earnings of 4 cents a share - Earnings Preview
Brief: Arcutis Biotherapeutics reports inducement grants under Nasdaq listing rule 5635(C)(4